Site Management/Investigator Payments Featured Articles

  1. How Laboratory Manuals Fail Sites And Sponsors 12/19/2024

    In part one of this series, FlexPoint Bio Founder and CEO Elena Sinclair describes the hazards of poorly designed (and followed) clinical trial lab manuals.

  2. Lab Manual Gaps: Sabotaging Data One Sample At A Time 12/19/2024

    In part two of this series on lab manuals, FlexPoint Bio Founder and CEO Elena Sinclair discusses the criticality of sample and process quality.

  3. BeiGene Details Its Approach To Expanding Oncology Trials Into Brazil 12/17/2024

    In this second article, BeiGene's Lígia Campos details its journey to setting roots in Brazil, sharing its beginnings there and highlighting its approach to study start-up and patient recruitment and enrollment.

  4. Should We Be Scared Of PE Firms Investing In Sites? 12/16/2024

    It seems lately there's been a lot of vilification of private equity (PE) firms that are purchasing site networks. I'm sure this sentiment has increased during the past few years, but is it justified? 

  5. BeiGene Explains The Landscape Of Oncology Trials In Brazil 12/16/2024

    In part one of this two-part series, BeiGene's Brazil and LATAM clinical operations head Lígia Campos details Brazil's cancer treatment landscape and the benefits of expanding oncology trials there.

  6. How To Work With A Research-Naïve Clinical Trial Site 12/12/2024

    Curo Research COO Amy Bland explores the potential of research-naive sites and offers actionable strategies sponsors can use to maximize their success in partnering with them.

  7. Is Clinical Research Inclusive Or Extractive? 12/6/2024

    Pulling from the concept of "inclusive" and "extractive" discussed in recent coverage of research conducted by Nobel Prize in Economics winners, Eduardo F. Motti discusses the give and take in the clinical trials industry.

  8. Were There Any Surprises In Clinical Trials In 2024? 12/4/2024

    Is it any surprise that when I asked a group of clinical trial industry experts to summarize some of the things that stood out to them in 2024, that AI would be mentioned more than once? Probably not. Resistance to DCTs, increasing regulatory scrutiny, and a slowdown in CRO M&As also made their lists — but I’m guessing none of that surprises you, either.

  9. What's Trending In Medical Devices And Diagnostics For 2025? 12/4/2024

    Four program directors from the Medical Device Innovation Consortium (MDIC) share their predictions on the trends that will drive innovation and reshape clinical research in 2025.

  10. Site Capabilities — The Hidden Drivers Of Clinical Trial Success 11/26/2024

    We've overcomplicated site selection, says Stryde Research CEO Chintan Desai. Here, Desai details what qualities sponsors should really look for in sites and why some of our existing criteria aren't cutting it.